JZUS - Journal of Zhejiang University SCIENCE

Journal of Zhejiang University SCIENCE B 2014 Vol.15 No.3 P.243-255

Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies*

Author(s): Jie Ding¹, Hui Xu², Xiang Yin¹, Fu-rong Zhang¹, Xiao-ping Pan³, Yi-an Gu⁴, Jun-zhu Chen¹, Xiao-gang Guo¹
Affiliation(s): 1. Department of Cardiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China; more
Corresponding email(s): gxg22222@zju.edu.cn
Key Words: Estrogen receptor &alpha, gene, Polymorphism, Meta-analysis, Coronary artery disease (CAD)

Share this article to： More <<< Previous Article \|Next Article >>>

Jie Ding, Hui Xu, Xiang Yin, Fu-rong Zhang, Xiao-ping Pan, Yi-an Gu, Jun-zhu Chen, Xiao-gang Guo. Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies[J]. Journal of Zhejiang University Science B, 2014, 15(3): 243-255.

@article{title="Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies",
author="Jie Ding, Hui Xu, Xiang Yin, Fu-rong Zhang, Xiao-ping Pan, Yi-an Gu, Jun-zhu Chen, Xiao-gang Guo",
journal="Journal of Zhejiang University Science B",
volume="15",
number="3",
pages="243-255",
year="2014",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1300220"
}

%0 Journal Article
%T Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies
%A Jie Ding
%A Hui Xu
%A Xiang Yin
%A Fu-rong Zhang
%A Xiao-ping Pan
%A Yi-an Gu
%A Jun-zhu Chen
%A Xiao-gang Guo
%J Journal of Zhejiang University SCIENCE B
%V 15
%N 3
%P 243-255
%@ 1673-1581
%D 2014
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1300220

TY - JOUR
T1 - Estrogen receptor α gene PvuII polymorphism and coronary artery disease: a meta-analysis of 21 studies
A1 - Jie Ding
A1 - Hui Xu
A1 - Xiang Yin
A1 - Fu-rong Zhang
A1 - Xiao-ping Pan
A1 - Yi-an Gu
A1 - Jun-zhu Chen
A1 - Xiao-gang Guo
J0 - Journal of Zhejiang University Science B
VL - 15
IS - 3
SP - 243
EP - 255
%@ 1673-1581
Y1 - 2014
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1300220

Abstract
Chinese Summary
Academic Network
Reviewer Comment

Abstract: The association between the estrogen receptor α gene (ESR1) PvuII polymorphism (c.454-397T>C) and coronary artery disease (CAD) is controversial. Thus, we conducted a meta-analysis to evaluate the relationship. Data were collected from 21 studies encompassing 9926 CAD patients and 16 710 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the relationship between PvuII polymorphism and CAD. The polymorphism in control populations in all studies followed Hardy-Weinberg equilibrium. We found a significant association between ESR1 PvuII polymorphism and CAD risk in all subjects. When the data were stratified by region, a significant association between ESR1 PvuII polymorphism and CAD risk was observed in Asian populations but not in Western populations. The current study suggests that ESR1 PvuII polymorphism has an important role in CAD susceptibility.

雌激素受体α基因PvuII基因多态性与冠心病关系的meta分析

研究目的：系统评价雌激素受体α基因PvuII 基因多态性与冠心病的关系。
创新要点：目前关于雌激素受体α基因PvuII基因多态性（c.454-397T>C）与冠心病的关系仍存在争议。因此本研究针对这一问题系统收集国内外符合纳入与排除标准的研究，通过meta分析，系统地评估雌激素受体α基因PvuII 基因多态性与冠心病的关系。
研究方法：针对研究问题系统检索国内外相关数据库，根据事先制定的纳入与排除标准及质量评价量表，筛选出符合标准的研究文献。利用STATA11.0和RevMan 5.2软件对纳入的21篇研究（包括9926病例和16710对照）进行定量分析。优势比（OR）值及95%置信区间（CI）用来衡量雌激素受体α基因PvuII基因多态性与冠心病的关系。
重要结论：Meta分析结果提示，雌激素受体α基因ESR1 PvuII基因多态性与冠心病的关系在研究的整体人群中有重要意义。地区亚组分析显示，在亚洲人群中，雌激素受体α基因PvuII基因多态性与冠心病相关，然而这种相关性不存在于西方人群。

关键词：雌激素受体α；基因多态性；冠心病；Meta分析

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References

[1] Alevizaki, M., Saltiki, K., Cimponeriu, A., 2007. Severity of cardiovascular disease in postmenopausal women: associations with common estrogen receptor α polymorphic variants. Eur J Endocrinol, 156(4):489-496.

[2] Almeida, S., Hutz, M.H., 2006. Estrogen receptor 1 gene polymorphisms and coronary artery disease in the Brazilian population. Braz J Med Biol Res, 39(4):447-454.

[3] Batchelor, W.B., Ellis, S.G., Ormiston, J.A., 2013. Racial differences in long-term outcomes after percutaneous coronary intervention with paclitaxel-eluting coronary stents. J Interv Cardiol, 26(1):49-57.

[4] Begg, C.B., Mazumdar, M., 1994. Operating characteristics of a rank correlation test for publication bias. Biometrics, 50(4):1088-1101.

[5] Boroumand, M., Ghaedi, M., Mohammadtaghvaei, N., 2009. Association of estrogen receptor α gene polymorphism with the presence of coronary artery disease documented by coronary angiography. Clin Biochem, 42(9):835-839.

[6] Camargo, M.C., Mera, R., Correa, P., 2006. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 15(9):1674-1687.

[7] Cheng, A.J., Fu, N.K., Xu, J., 2006. A study of the correlation between estrogen receptor gene polymorphism and coronary heart disease as well as serum lipid levels in postmenopausal women. Hebei Med J, (in Chinese),28(7):568-570.

[8] Cochran, W.G., 1968. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24(2):295-313.

[9] Egger, M., Davey Smith, G., Schneider, M., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109):629-634.

[10] Figtree, G.A., McDonald, D., Watkins, H., 2003. Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation, 107(1):120-126.

[11] Figtree, G.A., Noonan, J.E., Bhindi, R., 2009. Estrogen receptor polymorphisms: significance to human physiology, disease and therapy. Recent Pat DNA Gene Seq, 3(3):164-171.

[12] Grady, D., Rubin, S.M., Petitti, D.B., 1992. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med, 117(12):1016-1037.

[13] Grodstein, F., Stampfer, M.J., Colditz, G.A., 1997. Postmenopausal hormone therapy and mortality. N Engl J Med, 336(25):1769-1775.

[14] Guo, Z.G., Zheng, H., Wu, S.Z., 2002. Relationship between estrogen receptor gene polymorphism and coronary heart disease. Chin J Geriatr Cardiovasc Cerebrovasc Dis, (in Chinese),4(6):374-377.

[15] Gurevitz, O., Jonas, M., Boyko, V., 2000. Clinical profile and long-term prognosis of women ≤50 years of age referred for coronary angiography for evaluation of chest pain. Am J Cardiol, 85(7):806-809.

[16] Hamada, H., Kim, M.K., Iwakura, A., 2006. Estrogen receptors α and β mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation, 114(21):2261-2270.

[17] Herrington, D.M., Howard, T.D., Brosnihan, K.B., 2002. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation, 105(16):1879-1882.

[18] Higgins, J.P., Thompson, S.G., 2002. Quantifying heterogeneity in a meta-analysis. Stat Med, 21(11):1539-1558.

[19] Higgins, J.P., Thompson, S.G., Deeks, J.J., 2003. Measuring inconsistency in meta-analyses. BMJ, 327(7414):557-560.

[20] Huang, X.Z., Zhang, P.A., Li, Y., 2002. Association of estrogen receptor gene polymorphism with coronary heart disease. Chin J Cardiol, (in Chinese),30(2):78-81.

[21] Ioana, M., Ferwerda, B., Plantinga, T.S., 2012. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect Immun, 80(5):1917-1922.

[22] Jesmin, S., Mowa, C.N., Sultana, S.N., 2010. VEGF signaling is disrupted in the hearts of mice lacking estrogen receptor alpha. Eur J Pharmacol, 641(2-3):168-178.

[23] Jin, L.Z., Chen, X.C., Ma, Y.D., 2010. Association of estrogen receptor α gene PvuII and XbaI polymorphisms with coronary artery disease. Chin J Biomed Eng, (in Chinese),16(2):136-139.

[24] Jneid, H., 2012. The 2012 ACCF/AHA focused update of the unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) guideline: a critical appraisal. Methodist Debakey Cardiovasc J, 8(3):26-30.

[25] Karadağ, B., Gven, M., Hacioğlu, Y., 2009. Relationship between two estrogen receptor-α gene polymorphisms and angiographic coronary artery disease. Anadolu Kardiyol Derg, 9(4):267-272.

[26] Kjaergaard, A.D., Ellervik, C., Tybjærg-Hansen, A., 2007. Estrogen receptor α polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and case-control studies and a meta-analysis. Circulation, 115(7):861-871.

[27] Klos, K.L., Boerwinkle, E., Ferrell, R.E., 2008. ESR1 polymorphism is associated with plasma lipid and apolipoprotein levels in Caucasians of the Rochester Family Heart Study. J Lipid Res, 49(8):1701-1706.

[28] Koch, W., Hoppmann, P., Pfeufer, A., 2005. No replication of association between estrogen receptor α gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation, 112(14):2138-2142.

[29] Kunnas, T.A., Laippala, P., Penttil, A., 2000. Association of polymorphism of human α oestrogen receptor gene with coronary artery disease in men: a necropsy study. BMJ, 321(7256):273-274.

[30] Labont, B., Suderman, M., Maussion, G., 2012. Genome-wide epigenetic regulation by early-life trauma. Arch Gen Psychiatry, 69(7):722-731.

[31] Li, L.H., Zhao, F.M., Li, G.Q., 2006. Association between estrogen receptor alpha gene variation and risks of cardiovascular disease. Mol Cardiol China, (in Chinese),6(2):90-94.

[32] Liu, H., Pedram, A., Kim, J.K., 2011. Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β. Cardiovasc Res, 89(1):119-128.

[33] Llus-Ganella, C., Lucas, G., Subirana, I., 2009. Qualitative assessment of previous evidence and an updated meta-analysis confirms lack of association between the ESR1 rs2234693 (PvuII) variant and coronary heart disease in men and women. Atherosclerosis, 207(2):480-486.

[34] Lu, H., Higashikata, T., Inazu, A., 2002. Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol, 22(5):817-823.

[35] Mansur, A.P., Nogueira, C.C.M., Strunz, C.M.C., 2005. Genetic polymorphisms of estrogen receptors in patients with premature coronary artery disease. Arch Med Res, 36(5):511-517.

[36] Matsubara, Y., Murata, M., Kawano, K., 1997. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol, 17(11):3006-3012.

[37] Mendelsohn, M.E., Karas, R.H., 2005. Molecular and cellular basis of cardiovascular gender differences. Science, 308(5728):1583-1587.

[38] Peter, I., Shearman, A.M., Zucker, D.R., 2005. Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens, 23(12):2193-2200.

[39] Rokach, A., Pollak, A., Rosen, L., 2005. Estrogen receptor α gene polymorphisms are associated with the angiographic extent of coronary artery disease. J Clin Endocrinol Metab, 90(12):6556-6560.

[40] Rossouw, J.E., Anderson, G.L., Prentice, R.L., 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 288(3):321-333.

[41] Schuit, S.C.E., Oei, H.H., Witteman, J.C.M., 2004. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA, 291(24):2969-2977.

[42] Shearman, A.M., Cupples, L.A., Demissie, S., 2003. Association between estrogen receptor α gene variation and cardiovascular disease. JAMA, 290(17):2263-2270.

[43] Shen, C., Chen, J., Fan, S., 2012. Association between the polymorphism of estrogen receptor α and coronary artery disease in a Chinese population. Eur J Intern Med, 23(2):175-178.

[44] Stampfer, M.J., Colditz, G.A., 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med, 20(1):47-63.

[45] St-Hilaire, S., Mandal, R., Commendador, A., 2011. Estrogen receptor positive breast cancers and their association with environmental factors. Int J Health Geogr, 10:32

[46] Tang, Z.Z., Li, X.P., Yang, J.H., 2008. Relationship of estrogen receptor α gene polymorphism and risk of cardiovascular diseases. Mil Med J South China, (in Chinese),22(2):35-37.

[47] Thakkinstian, A., McEvoy, M., Minelli, C., 2005. Systematic review and meta-analysis of the association between β₂-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol, 162(3):201-211.

[48] Thomas, K.L., Honeycutt, E., Shaw, L.K., 2010. Racial differences in long-term survival among patients with coronary artery disease. Am Heart J, 160(4):744-751.

[49] Tunstall-Pedoe, H., Kuulasmaa, K., Mhnen, M., 1999. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet, 353(9164):1547-1557.

[50] Wang, F., He, Q., Sun, Y., 2010. Female adult mouse cardiomyocytes are protected against oxidative stress. Hypertension, 55(5):1172-1178.

[51] Wei, C.D., Zheng, H.Y., Wu, W., 2013. Meta-analysis of the association of the rs2234693 and rs9340799 polymorphisms of estrogen receptor alpha gene with coronary heart disease risk in Chinese Han population. Int J Med Sci, 10(4):457-466.

[52] Wright, R.S., Anderson, J.L., Adams, C.D., 2011. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 57(19):e215-e367.

[53] Xu, H., Hou, X., Wang, N., 2008. Gender-specific effect of estrogen receptor-1 gene polymorphisms in coronary artery disease and its angiographic severity in Chinese population. Clin Chim Acta, 395(1-2):130-133.

[54] Yaich, L., Dupont, W.D., Cavener, D.R., 1992. Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood. Cancer Res, 52(1):77-83.

[55] Yilmaz, A., Menevse, S., Erkan, A.F., 2007. The relationship of the ESR1 gene polymorphisms with the presence of coronary artery disease determined by coronary angiography. Genet Test, 11(4):367-371.

[56] Yu, Q., Liu, E.Q., Zhao, S.H., 2012. Association between TaqIB polymorphism of cholesteryl ester transfer protein and coronary artery disease in the Chinese population. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 13(5):342-347.

[57] Zheng, H.M., 2002. Association of Estrogen Receptor (ER) Polymorphisms with Coronary Artery Disease and the Lipoprotein Metabolism in Women. MS Thesis, (in Chinese), Hebei Medical University,Hebei, China :

Similar articles

- Go to

雌激素受体α基因PvuII基因多态性与冠心病关系的meta分析

Darkslateblue:Affiliate; Royal Blue:Author; Turquoise:Article

References